Atlas Trials

Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With Cancer

Clinical trial NCT01989845 · COMPLETED

Trial details

NCT number
NCT01989845
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
RivaroxabanCancer-associated ThrombosisRecurrenceBleeding
Start date
2013-10-01
Primary completion
2016-12-01
Enrollment
127

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.